Normal weight individuals with type 2 diabetes (NWD) have higher risk of mortality than overweight or obese individuals. NWD may have less lean muscle mass in proportion to adipose tissue, which may contribute to this higher risk of mortality. Strength training increases muscle mass rather than reducing body weight and can combat the age-related shift in body composition that results in higher fat mass and decreased muscle mass (i.e., sarcopenia). Thus, strength training may therefore be helpful for NWD rather than weight loss, as is recommended for overweight/obese individuals with type 2 diabetes (T2DM). Additionally, strength training in NWD could eliminate known differences in visceral adiposity across racial/ethnic groups. This may have significant implications for management of NWD. Currently, there is a lack of data on effective lifestyle recommendations for NWD, who can represent up to 1 in 5 individuals with T2DM. Physical activity recommendations emphasize aerobic exercise, which may not be appropriate for NWD. Body fat assessment, rather than body mass index, may be a better diagnostic tool in NWD, and better inform therapeutic lifestyle change interventions to control glucose and ultimately alleviate the significantly higher mortality discovered for this group. Strength training, rather than aerobic-focused regimens, may be a more appropriate treatment recommendation. In order to determine the best exercise regimen for NWD, we propose to implement a three- arm randomized control trial comparing the clinical effectiveness of strength training vs. aerobic training vs. combined (strength + aerobic) training for T2DM management among NWD at the Palo Alto Medical Foundation (PAMF), a large, community-based, multi-specialty ambulatory care setting. The primary outcome for measurement will be improvement in T2DM control (e.g., % hemoglobin A1c reduction). Process measures will include changes in physical fitness (e.g., VO2 max), and change in body composition (DEXA scans).While the benefits of combined (strength + aerobic) activity have been well demonstrated in overweight/obese diabetics, there currently exists little evidence to recommend this regimen in NWD. The goal of the Strength Training Regimen for Normal weiGht Diabetics (STRONG-D) Study is to determine the best exercise regimen for NWD, who experience greater mortality than overweight/obese diabetics.

Public Health Relevance

Normal weight individuals with type 2 diabetes experience higher mortality than overweight or obese individuals with type 2 diabetes, but there is little evidence on treatment for this high risk population. The proposed study will inform which exercise recommendation - strength training, aerobic training, or combination strength and aerobic training - is most effective in treating type 2 diabetes among individuals at normal weight, who can represent up to 1 in 5 individuals with type 2 diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK081371-06
Application #
8693480
Study Section
Kidney, Nutrition, Obesity and Diabetes Study Section (KNOD)
Program Officer
Bremer, Andrew
Project Start
2008-07-01
Project End
2019-03-31
Budget Start
2014-04-15
Budget End
2015-03-31
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Palo Alto Medical Foundation Research Institute
Department
Type
DUNS #
City
Palo Alto
State
CA
Country
United States
Zip Code
94301
Zhao, Beinan; Jose, Powell O; Pu, Jia et al. (2015) Racial/ethnic differences in hypertension prevalence, treatment, and control for outpatients in northern California 2010-2012. Am J Hypertens 28:631-9
Chung, Sukyung; Zhao, Beinan; Lauderdale, Diane et al. (2015) Initiation of treatment for incident diabetes: evidence from the electronic health records in an ambulatory care setting. Prim Care Diabetes 9:23-30
Azar, Kristen M J; Chung, Sukyung; Wang, Elsie J et al. (2015) Impact of Education on Weight in Newly Diagnosed Type 2 Diabetes: Every Little Bit Helps. PLoS One 10:e0129348
Romanelli, Robert J; Chung, Sukyung; Pu, Jia et al. (2015) Comparative effectiveness of early versus delayed metformin in the treatment of type 2 diabetes. Diabetes Res Clin Pract 108:170-8
Pu, Jia; Romanelli, Robert; Zhao, Beinan et al. (2015) Dyslipidemia in special ethnic populations. Cardiol Clin 33:325-33
Thompson, Caroline A; Gomez, Scarlett Lin; Chan, Albert et al. (2014) Patient and provider characteristics associated with colorectal, breast, and cervical cancer screening among Asian Americans. Cancer Epidemiol Biomarkers Prev 23:2208-17
Chung, Sukyung; Azar, Kristen M J; Baek, Marshall et al. (2014) Reconsidering the age thresholds for type II diabetes screening in the U.S. Am J Prev Med 47:375-81
Frank, Ariel T H; Zhao, Beinan; Jose, Powell O et al. (2014) Racial/ethnic differences in dyslipidemia patterns. Circulation 129:570-9
Holland, Ariel T; Zhao, Beinan; Wong, Eric C et al. (2013) Racial/ethnic differences in control of cardiovascular risk factors among type 2 diabetes patients in an insured, ambulatory care population. J Diabetes Complications 27:34-40
Bhalla, Vivek; Zhao, Beinan; Azar, Kristen M J et al. (2013) Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease. Diabetes Care 36:1215-21

Showing the most recent 10 out of 24 publications